Presentation TCT 2020 The PROSPECT ABSORB Trial: Randomized Evaluation of Vulnerable Plaque Treatment with Percutaneous Coronary Intervention Presenter: Gregg Stone October 14, 2020 REGISTER for free or LOG IN to view this content Coronary Plaque Modification Presentation TCT 2020 Gregg Stone PCI PROSPECT ABSORB Trial Vulnerable plaques Percutaneous coronary intervention Up Next Presentation TCT 2020 Initial Outcomes from NACMI The North American COVID-19 STEMI Registry Presenter: Timothy Henry October 14, 2020 More slides + Presentation TCT 2020 Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial Presenter: George Vlachojannis October 14, 2020 Presentation TCT 2020 TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI Presenter: Byeong-Keuk Kim October 14, 2020 We Recommend
Presentation TCT 2020 Initial Outcomes from NACMI The North American COVID-19 STEMI Registry Presenter: Timothy Henry October 14, 2020
Presentation TCT 2020 Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial Presenter: George Vlachojannis October 14, 2020
Presentation TCT 2020 TICO-STEMI: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in STEMI Presenter: Byeong-Keuk Kim October 14, 2020